Autoimmune hepatitis as an adverse effect of long-term methotrexate therapy

Indian Journal of Pharmacology

Volumn 46, Issue 6, 2014, Pages 649-650

  Ksouda, Kamilia ^a   Affes, Hanen ^a   Atheymen, Rim ^a   Ezzeddine, Mariem ^b   Zeghal, Khaled ^a   Hammami, Serria ^a  

^a UNIVERSITY OF SFAX   (Tunisia)

^b HEDI CHAKER HOSPITAL   (Tunisia)

Author keywords

Autoimmune hepatitis; drug induced autoimmunity; methotrexate; psoriatic arthritis

Indexed keywords

ALANINE AMINOTRANSFERASE; ALBUMIN; ANTINUCLEAR ANTIBODY; ASPARTATE AMINOTRANSFERASE; GAMMA GLUTAMYLTRANSFERASE; IMMUNOGLOBULIN G; METHOTREXATE; METHYLPREDNISOLONE; MITOCHONDRION ANTIBODY; ALKALINE PHOSPHATASE; ANTIRHEUMATIC AGENT;

ABDOMINAL RADIOGRAPHY; ADULT; ALANINE AMINOTRANSFERASE BLOOD LEVEL; ALBUMIN BLOOD LEVEL; ANTIBODY TITER; ARTICLE; ASPARTATE AMINOTRANSFERASE BLOOD LEVEL; ASTHENIA; AUTOIMMUNE HEPATITIS; CASE REPORT; DRUG WITHDRAWAL; FEMALE; GAMMA GLUTAMYL TRANSFERASE BLOOD LEVEL; HUMAN; JAUNDICE; LONG TERM CARE; MIDDLE AGED; PROTHROMBIN TIME; PSORIATIC ARTHRITIS; REMISSION; TREATMENT DURATION; ULTRASOUND; WEIGHT REDUCTION; ARTHRITIS, PSORIATIC; BLOOD; DRUG-INDUCED LIVER INJURY; HEPATITIS, AUTOIMMUNE;

ALANINE TRANSAMINASE; ALKALINE PHOSPHATASE; ANTIRHEUMATIC AGENTS; ARTHRITIS, PSORIATIC; ASPARTATE AMINOTRANSFERASES; DRUG-INDUCED LIVER INJURY; FEMALE; GAMMA-GLUTAMYLTRANSFERASE; HEPATITIS, AUTOIMMUNE; HUMANS; METHOTREXATE; MIDDLE AGED; PROTHROMBIN TIME;

EID: 84916224082     PISSN: 02537613     EISSN: 19983751     Source Type: Journal    
DOI: 10.4103/0253-7613.144940     Document Type: Article

References (9)

1. Alves JA, Fialho SC, Morato EF, Castro GR, Zimmermann AF, Ribeiro GG, et al. Liver toxicity is rare in rheumatoid arthritis patients using combination therapy with lefl unomide and methotrexate. Rev Bras Reumatol 2011; 51: 141-4
2. van Swelm RP, Laarakkers CM, Kooijmans-Otero M, de Jong EM, Masereeuw R, Russel FG. Biomarkers for methotrexate-induced liver injury: Urinary protein profi ling of psoriasis patients. Toxicol Lett 2013; 221: 219-24
3. Xiao X, Chang C. Diagnosis and classifi cation of drug-induced autoimmunity (DIA). J Autoimmun 2014; 48-49: 66-72
4. Stamp L, Roberts R, Kennedy M, Barclay M, O'Donnell J, Chapman P. The use of low dose methotrexate in rheumatoid arthritis-Are we entering a new era of therapeutic drug monitoring and pharmacogenomics? Biomed Pharmacother 2006; 60: 678-87
5. The use of the WHO-UMC system for standardized case causality assessment [monograph on the Internet]. Uppsala: The Uppsala Monitoring Centre; 2005. Available from: Http://www.who-umc.org/Graphics/24734.pdf. [Last accessed on 2011 May 06]
6. Naranjo CA, Busto U, Sellers EM, Sandor P, Ruiz I, Roberts EA, et al. A method for estimating the probability of adverse drug reactions. Clin Pharmacol Ther 1981; 30: 239-45
7. Danan G, Benichou C. Causality assessment of adverse reactions to drugs-I. A novel method based on the conclusions of international consensus meetings: Application to drug-induced liver injuries. J Clin Epidemiol 1993; 46: 1323-30
8. Moreno-Otero R, García-Buey L, García-Sanchez A, Trapero-Marugán M. Autoimmune hepatitis after long-Term methotrexate therapy for rheumatoid arthritis. Curr Drug Saf 2011; 6: 197-200
9. Germano V, Picchianti Diamanti A, Baccano G, Natale E, Onetti Muda A, Priori R, et al. Autoimmune hepatitis associated with infl iximab in a patient with psoriatic arthritis. Ann Rheum Dis 2005; 64: 1519-20